Upstate Active Clinical Trials
Study Title:
A PHASE 3, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF RELDESEMTIV IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)Upstate Institutional Review Board (IRB) Number:
1679698Patient Age Group:
AdultsPrincipal Investigator:
Deborah Y BradshawWho can I contact for more information?
Name: Sigiriya E Smolen
Phone: 315-464-9767
Email: [email protected]